Login to Your Account

The Problem with Local Brews

Money, Science Issues Lead to Biomarker Bargain Basement

By Anette Breindl
Science Editor

Monday, August 19, 2013

Biomarkers would seem to have it all – they could save money for the health care system by saving patients ineffective care and its attendant toxicity risks. But considering how useful they are, there are a surprisingly low number of biomarkers in widespread clinical use. "The way it's been going for the last 30 years has resulted in very few validated biomarkers," Dan Hayes told BioWorld Insight.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription